Gold note: biological and heart age are calculated at maximum confidence here, anchored by real body-composition data from the Morpho Nova scan rather than estimates. The visceral fat finding has raised both ages slightly versus a Silver estimate.
| Medication | Dose | Pharmacist note |
|---|---|---|
| Amlodipine | 5mg OD | For BP. May need dose review given current readings โ discuss with GP. |
| Atorvastatin | 20mg ON | Appropriate given QRISK3 >10%. Continue; recheck lipids at GP review. |
| Cod liver oil (OTC) | 1 daily | No interaction. Adequate omega-3; vitamin D content modest โ consider 10mcg D3 OctโMar. |
Generated using current NICE/WHO guidelines ยท Clinician-reviewed ยท Maximum data confidence
Your Gold assessment, anchored by precision body-composition data, shows a metabolic risk profile centred on visceral adiposity. Your biological age is 57 and heart age 61. The standout finding is a visceral fat level of 12 (target โค9) combined with a QRISK3 of 11.2% โ together these point clearly to where the greatest gains lie. The reassuring news: adequate muscle mass gives you a strong foundation, and visceral fat is one of the most responsive markers to lifestyle change.
The key changes to maintain or improve your health score of 63/100